{"componentChunkName":"component---src-templates-topic-topic-tsx","path":"/topics/hepatitis-b/","result":{"data":{"firstChapter":{"id":"986057cd-07a1-565e-9c7a-d3b3dc88368d","slug":"summary","fullItemName":"Summary","subChapters":[],"depth":1,"htmlHeader":"<!-- begin field 8c5d6bfd-9d0f-40e1-9ec3-7f5c7b63ab07 --><h1>Hepatitis B: Summary</h1><!-- end field 8c5d6bfd-9d0f-40e1-9ec3-7f5c7b63ab07 -->","htmlStringContent":"<!-- begin item 8c2a0fe2-bca7-427c-aaec-fece94080f5a --><!-- begin field fbc44e5d-b84a-45ce-bb8d-0b79642c317a --><ul><li>Hepatitis B is an infectious disease of the liver caused by the hepatitis B virus.</li><li>The prevalence of people with antibodies to hepatitis B core antigen (anti-HBc) — a marker of current or previous infection (seroprevalence) — is 1–2% in the UK. In parts of China and South Korea, the seroprevalence is 96%.</li><li>In the UK, most new infections are acquired in adulthood. The source of infection is most commonly via sexual contact or sharing equipment for injecting drugs with other people with chronic hepatitis B.</li><li>Acute hepatitis B symptoms and jaundice generally last for 1–3 months. Hepatitis B surface antigen (HBsAg) is cleared in around 95% of immunocompetent adults. Fulminant hepatitis occurs in less than 1% of people, but can be fatal.</li><li>Chronic hepatitis B infection is the persistence of serum HBsAg for more than 6 months.<ul><li>It occurs in approximately 10% of infants born to hepatitis B–positive mothers (if not immunized at birth); between 10% and 20% of children infected in later childhood, and about 5% of people infected as healthy adults.</li><li>Most people with chronic hepatitis B infection are asymptomatic.</li><li>A minority of people with chronic hepatitis B infection will develop chronic active hepatitis.</li><li>Cirrhosis develops in about 15–20% of people infected as healthy adults but may take as long as 20 years to manifest.</li><li>Hepatocellular cancer develops in about 10% of people who progress to cirrhosis, and is detected an average of 30 years after initial hepatitis B infection.</li></ul></li><li>Management of a person with hepatitis B infection includes:<ul><li>Admission if they are severely unwell, <em>or </em>referral to a liver specialist for follow-up, monitoring, and any required treatment. Pre-treatment blood tests and a liver ultrasound scan should be arranged, with results forwarded to the specialist.</li><li>Offering symptomatic supportive treatment (rest, pain relief, and treatment of nausea and itch) if needed while the person is awaiting referral.</li><li>Notifying the Health Protection Unit.</li><li>Offering advice including to avoid alcohol, and preventing transmission of infection.</li><li>Offering referral to a genito-urinary medicine clinic and/or drug rehabilitation agency, if appropriate.</li></ul></li><li>In people with confirmed chronic hepatitis B infection, specialist monitoring will be required and antiviral treatment may be offered depending on the findings of a number of investigations.</li></ul><!-- end field fbc44e5d-b84a-45ce-bb8d-0b79642c317a --><!-- end item 8c2a0fe2-bca7-427c-aaec-fece94080f5a -->","topic":{"id":"f75dcfde-3cb4-5059-94df-19d53a6c28e9","topicId":"4fc86266-0752-4667-994f-7f6fc7e46056","topicName":"Hepatitis B","slug":"hepatitis-b","aliases":[],"chapters":[{"id":"986057cd-07a1-565e-9c7a-d3b3dc88368d","slug":"summary","fullItemName":"Summary","subChapters":[]},{"id":"2331f5c5-fb51-54d1-b722-946b4f34a693","slug":"have-i-got-the-right-topic","fullItemName":"Have I got the right topic?","subChapters":[]},{"id":"653459fe-510a-5a1a-92dc-8197c598c85e","slug":"how-up-to-date-is-this-topic","fullItemName":"How up-to-date is this topic?","subChapters":[{"id":"12e8fb8c-9424-5f20-90e5-65e823f603c3","slug":"changes","fullItemName":"Changes"},{"id":"2299e2ba-3fb3-5f37-9c6b-63ec8dbbffd6","slug":"update","fullItemName":"Update"}]},{"id":"c14d3383-629b-5bd6-b6c0-318bbcf86fb2","slug":"goals-outcome-measures","fullItemName":"Goals and outcome measures","subChapters":[{"id":"58e5cd67-9ca7-5bfe-b2b6-bf4372ac895f","slug":"goals","fullItemName":"Goals"},{"id":"a1abbdfd-238b-55b7-8de2-09fd4ff6065b","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"fc44420e-13ab-526e-a0c7-ef2f93cce77b","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"b59d4642-5914-585b-82b1-6f7989cef100","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"af246587-2615-513e-aafc-3ea762d8aab7","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"bba17b9f-47f8-52cf-a8e7-111c1a5094a2","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"2c6fa000-50a2-5823-9acb-0bd808dc51e6","slug":"background-information","fullItemName":"Background information","subChapters":[{"id":"dfcb6ed4-783a-5fbc-9259-096762bb7c69","slug":"definition","fullItemName":"Definition"},{"id":"e06f78dc-080c-542f-b450-356db08c00a9","slug":"prevalence","fullItemName":"Prevalence"},{"id":"0c1d15cf-36ee-5c84-ad7c-e06836a161c0","slug":"transmission","fullItemName":"Transmission"},{"id":"939f1d6a-6b15-5c4f-91c8-9164e800cd87","slug":"people-at-high-risk-of-hepatitis-b","fullItemName":"People at high risk of hepatitis B"},{"id":"d452f04a-7d9d-5739-9cb9-f583eb136f3a","slug":"complications-prognosis","fullItemName":"Complications and prognosis"}]},{"id":"b3642d36-7175-548b-b6f0-d694e7397bd3","slug":"diagnosis","fullItemName":"Diagnosis","subChapters":[{"id":"6acbd5e1-b0e6-527b-bad0-42c21a928d1e","slug":"when-to-test-for-hepatitis-b","fullItemName":"When to test for hepatitis B"},{"id":"706362c9-e255-511b-83b4-74b853c926c7","slug":"how-to-test-for-hepatitis-b","fullItemName":"How to test for hepatitis B"},{"id":"c0c1ae56-2316-56eb-ad65-4b85e982fc11","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"41c2681f-bf40-5b08-a518-32f2ab1206fb","slug":"management","fullItemName":"Management","subChapters":[{"id":"b2d949a2-a42f-5c0a-a955-414bac741bd3","slug":"prevention-of-infection-with-hepatitis-b","fullItemName":"Scenario: Prevention of infection with Hepatitis B"},{"id":"00ed825c-5927-50f5-940d-94d6b4001150","slug":"managing-hepatitis-b-infection","fullItemName":"Scenario: Managing hepatitis B infection"}]},{"id":"c7941282-a3b2-5716-b0cc-80cb243a7405","slug":"prescribing-information","fullItemName":"Prescribing information","subChapters":[{"id":"8df28bde-0bc5-533e-a54b-507fd3ceee61","slug":"hepatitis-b-vaccine","fullItemName":"Hepatitis B vaccine"},{"id":"c7099851-c102-56f2-b063-021f3d00b880","slug":"analgesics","fullItemName":"Analgesics"},{"id":"6a9675fd-5496-5ca4-9a76-36ee6cc93a25","slug":"anti-emetics","fullItemName":"Anti-emetics"},{"id":"1576eb24-e96c-50e6-9976-05164be1127e","slug":"anti-pruritics","fullItemName":"Anti-pruritics"}]},{"id":"3c7651c1-b246-51db-85b3-e1b6713a47bd","slug":"supporting-evidence","fullItemName":"Supporting evidence","subChapters":[]},{"id":"548463b9-9c49-5154-bad9-fe10668804da","slug":"how-this-topic-was-developed","fullItemName":"How this topic was developed","subChapters":[{"id":"8b3032fc-e20a-509b-b390-81cef2509ded","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"5e0cdb38-e518-5a0c-9215-493c78f74377","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"3e63144c-a0f3-5eb1-980d-a219e8a53633","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"94d851c4-3314-5a3d-801a-0a208e287514","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"4df2edc1-d17c-57d1-a914-4100299c8f7d","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"cecf6c0b-d134-54cb-abef-c2ccab9effb6","slug":"references","fullItemName":"References","subChapters":[]}]}},"topic":{"id":"f75dcfde-3cb4-5059-94df-19d53a6c28e9","topicId":"4fc86266-0752-4667-994f-7f6fc7e46056","topicName":"Hepatitis B","slug":"hepatitis-b","aliases":[],"topicSummary":"Hepatitis B is an infectious disease of the liver caused by the hepatitis B virus.","lastRevised":"Last revised in November 2019","nextPlannedReviewBy":"2024-11-01T00:00:00+00:00","nextPlannedReviewByDateTime":"2024-11","nextPlannedReviewByDisplay":"November 2024","specialities":[{"id":"aa304738-44fc-5b1d-af3b-42cce5d27663","name":"Endocrine and metabolic","slug":"endocrine-metabolic"},{"id":"e4fd15e3-ef70-523f-843c-5270742f518d","name":"Gastrointestinal","slug":"gastrointestinal"},{"id":"e174a859-759f-5b1d-898e-1a4155645e13","name":"Infections and infestations","slug":"infections-infestations"}],"chapters":[{"id":"986057cd-07a1-565e-9c7a-d3b3dc88368d","slug":"summary","fullItemName":"Summary","subChapters":[]},{"id":"2331f5c5-fb51-54d1-b722-946b4f34a693","slug":"have-i-got-the-right-topic","fullItemName":"Have I got the right topic?","subChapters":[]},{"id":"653459fe-510a-5a1a-92dc-8197c598c85e","slug":"how-up-to-date-is-this-topic","fullItemName":"How up-to-date is this topic?","subChapters":[{"id":"12e8fb8c-9424-5f20-90e5-65e823f603c3","slug":"changes","fullItemName":"Changes"},{"id":"2299e2ba-3fb3-5f37-9c6b-63ec8dbbffd6","slug":"update","fullItemName":"Update"}]},{"id":"c14d3383-629b-5bd6-b6c0-318bbcf86fb2","slug":"goals-outcome-measures","fullItemName":"Goals and outcome measures","subChapters":[{"id":"58e5cd67-9ca7-5bfe-b2b6-bf4372ac895f","slug":"goals","fullItemName":"Goals"},{"id":"a1abbdfd-238b-55b7-8de2-09fd4ff6065b","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"fc44420e-13ab-526e-a0c7-ef2f93cce77b","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"b59d4642-5914-585b-82b1-6f7989cef100","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"af246587-2615-513e-aafc-3ea762d8aab7","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"bba17b9f-47f8-52cf-a8e7-111c1a5094a2","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"2c6fa000-50a2-5823-9acb-0bd808dc51e6","slug":"background-information","fullItemName":"Background information","subChapters":[{"id":"dfcb6ed4-783a-5fbc-9259-096762bb7c69","slug":"definition","fullItemName":"Definition"},{"id":"e06f78dc-080c-542f-b450-356db08c00a9","slug":"prevalence","fullItemName":"Prevalence"},{"id":"0c1d15cf-36ee-5c84-ad7c-e06836a161c0","slug":"transmission","fullItemName":"Transmission"},{"id":"939f1d6a-6b15-5c4f-91c8-9164e800cd87","slug":"people-at-high-risk-of-hepatitis-b","fullItemName":"People at high risk of hepatitis B"},{"id":"d452f04a-7d9d-5739-9cb9-f583eb136f3a","slug":"complications-prognosis","fullItemName":"Complications and prognosis"}]},{"id":"b3642d36-7175-548b-b6f0-d694e7397bd3","slug":"diagnosis","fullItemName":"Diagnosis","subChapters":[{"id":"6acbd5e1-b0e6-527b-bad0-42c21a928d1e","slug":"when-to-test-for-hepatitis-b","fullItemName":"When to test for hepatitis B"},{"id":"706362c9-e255-511b-83b4-74b853c926c7","slug":"how-to-test-for-hepatitis-b","fullItemName":"How to test for hepatitis B"},{"id":"c0c1ae56-2316-56eb-ad65-4b85e982fc11","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"41c2681f-bf40-5b08-a518-32f2ab1206fb","slug":"management","fullItemName":"Management","subChapters":[{"id":"b2d949a2-a42f-5c0a-a955-414bac741bd3","slug":"prevention-of-infection-with-hepatitis-b","fullItemName":"Scenario: Prevention of infection with Hepatitis B"},{"id":"00ed825c-5927-50f5-940d-94d6b4001150","slug":"managing-hepatitis-b-infection","fullItemName":"Scenario: Managing hepatitis B infection"}]},{"id":"c7941282-a3b2-5716-b0cc-80cb243a7405","slug":"prescribing-information","fullItemName":"Prescribing information","subChapters":[{"id":"8df28bde-0bc5-533e-a54b-507fd3ceee61","slug":"hepatitis-b-vaccine","fullItemName":"Hepatitis B vaccine"},{"id":"c7099851-c102-56f2-b063-021f3d00b880","slug":"analgesics","fullItemName":"Analgesics"},{"id":"6a9675fd-5496-5ca4-9a76-36ee6cc93a25","slug":"anti-emetics","fullItemName":"Anti-emetics"},{"id":"1576eb24-e96c-50e6-9976-05164be1127e","slug":"anti-pruritics","fullItemName":"Anti-pruritics"}]},{"id":"3c7651c1-b246-51db-85b3-e1b6713a47bd","slug":"supporting-evidence","fullItemName":"Supporting evidence","subChapters":[]},{"id":"548463b9-9c49-5154-bad9-fe10668804da","slug":"how-this-topic-was-developed","fullItemName":"How this topic was developed","subChapters":[{"id":"8b3032fc-e20a-509b-b390-81cef2509ded","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"5e0cdb38-e518-5a0c-9215-493c78f74377","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"3e63144c-a0f3-5eb1-980d-a219e8a53633","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"94d851c4-3314-5a3d-801a-0a208e287514","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"4df2edc1-d17c-57d1-a914-4100299c8f7d","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"cecf6c0b-d134-54cb-abef-c2ccab9effb6","slug":"references","fullItemName":"References","subChapters":[]}]}},"pageContext":{"id":"f75dcfde-3cb4-5059-94df-19d53a6c28e9"}},"staticQueryHashes":["3666801979"]}